Search Grant Opportunities

Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)

ID: PAR-23-063 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)

Description

The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 2 award is to strengthen successful COBRE Phase 1 centers established in Phase 1 through further improvements to research infrastructure and the continued development of a critical mass of investigators with shared scientific interests who are able to compete effectively for independent research funding and further improvements to research infrastructure at the institution.
Background
The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 2 award is to strengthen successful COBRE Phase 1 centers established in Phase 1 through further improvements to research infrastructure and the continued development of a critical mass of investigators with shared scientific interests who are able to compete effectively for independent research funding.

The Phase 2 award will also provide further improvements to research infrastructure at the institution.

Grant Details
To submit a Phase 2 application in response to this FOA, the applicant institution must have an active COBRE Phase 1 award and have established the necessary infrastructure to support research in the area of the Center. The COBRE Phase 2 program seeks to continue the development of a critical mass of investigators who can compete effectively for independent, external research funding. The Phase 2 award will provide research support and mentoring to faculty investigators as well as enhancements of the institution’s research infrastructure to facilitate research in the Center’s scientific area.

Applicant institutions should demonstrate their continued commitment to the COBRE program goals by investing in the recruitment and support of the Center’s investigators and the long-term sustainability of the research infrastructure.

Eligibility Requirements
Only COBRE Phase 1 Centers supported by an active award, including those in a no-cost-extension, are eligible to apply. RPLs must qualify as either NIH Early Stage Investigators (ESIs) or as New Investigators (NIs). They must also hold independent multi-year faculty appointments (or equivalent at research institutes) and be leading their own research programs.

Period of Performance
The project period is limited to five years.

Grant Value
Application budgets must not exceed $1.5 million in annual direct costs, excluding consortium facilities and administrative (F&A) costs.
Show All

Overview

Agency
National Institutes of Health (NIH) [HHS]
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
93.859 - Biomedical Research and Research Training
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 12/20/22 the National Institutes of Health posted grant opportunity PAR-23-063 for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional). The grant will be issued under grant program 93.859 Biomedical Research and Research Training.

Timing

Posted Date
Dec. 20, 2022, 12:00 a.m. EST
Closing Date
May 28, 2025, 12:00 a.m. EDT Past Due
Last Updated
Dec. 20, 2022, 9:41 a.m. EST
Version
1
Archive Date
July 3, 2025

Eligibility

Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Opportunity Announcement for additional details on eligibility

Award Sizing

Ceiling
$1,500,000
Floor
Not Listed
Estimated Program Funding
Not Provided
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
grantsinfo@nih.gov
Email Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Contact Phone
(301) 402-2541
Additional Information
https://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html
Additional Information Site
http://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html

Documents

Posted documents for PAR-23-063

Grant Awards

Grants awarded through PAR-23-063

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to PAR-23-063

Experts for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)

Recommended subject matter experts available for hire